Autopsy report · NCT05554055
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
Cause of deathStaffing, sites or logistics, also drug or device supply
“The AXAES study was stopped mainly for logistical and organizational reasons. The machine needed to carry out the examinations was no longer available, making it impossible to continue the study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Conditions
- Aortic Diseases; Arterial Disease; Thrombosis
- Interventions
- Anti Xa activity measurement.
- Participants
- 0
- Sites
- 1
- Countries
- France
Trials that died the same way
- Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
“The study was stopped because there were not enough eligible patients to complete the study.” - "Pilot Study: A Comparison of the Bouquet Speculum and the Traditional 2-Bladed Speculum"
“The study was stopped because of logistical issues with the sites.” - New Prophylactic Maneuver: the "Pushing" Maneuver, Aiming to Reduce the Risk for Shoulder Dystocia
“the study stopped due to the lack of inclusion.” - Comparing Palliative Radiotherapy With or Without Carboplatin
“The study was stopped due to insufficient recruitment.” - A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
“Study was stopped following interim analysis.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.